| 2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
| 2012 | Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir | LIVER INTERNATIONAL |
| 2009 | Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2012 | Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation | DIGESTIVE DISEASES AND SCIENCES |
| 2009 | Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis | LIVER INTERNATIONAL |
| 2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
| 2010 | Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
| ANTIVIRAL THERAPY |
| 2005 | Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance | JOURNAL OF HEPATOLOGY |
| 2005 | Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2006 | Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
| 2007 | Long-term outcome of chronic hepatitis B based on histological grade and stage | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2004 | Low grade gastric mucosa associated lymphoid tissue lymphoma; treatment strategies based on 10 year follow-up
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2014 | Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. | LIVER INTERNATIONAL |
| 2008 | MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
| CARCINOGENESIS |
| 2007 | MRP2 haplotypes confer differential susceptibility to toxic liver injury | PHARMACOGENETICS AND GENOMICS |
| 2008 | Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2010 | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression
| HEPATOLOGY INTERNATIONAL |
| 2007 | Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2016 | Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model. | DIGESTIVE DISEASES AND SCIENCES |
| 2013 | Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea | LIVER INTERNATIONAL |
| 2012 | Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2012 | "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2013 | Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
| CLINICAL CANCER RESEARCH |
| 2012 | Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
| 2009 | Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification | AMERICAN JOURNAL OF SURGERY |
| 2013 | Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B | DIGESTION |
| 2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |
| 2012 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
| PLOS ONE |
| 2008 | Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection | LIVER INTERNATIONAL |
| 2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
| 2007 | PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection | ONCOLOGY |
| 2012 | Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts | DIGESTION |
| 2012 | Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis
| PLOS ONE |
| 2008 | Prediction of microvascular invasion before curative resection of hepatocellular carcinoma | JOURNAL OF SURGICAL ONCOLOGY |
| 2008 | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study
| HEPATOLOGY INTERNATIONAL |
| 2012 | Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®) | ANNALS OF SURGICAL ONCOLOGY |
| 2011 | Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT | HEPATO-GASTROENTEROLOGY |
| 2011 | Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma | LIVER INTERNATIONAL |
| 2012 | Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers | LIVER INTERNATIONAL |
| 2008 | Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2013 | Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
| YONSEI MEDICAL JOURNAL |
| 2014 | Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis
| YONSEI MEDICAL JOURNAL |
| 2011 | Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. | EUROPEAN JOURNAL OF CANCER |
| 2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
| 2013 | Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation | EUROPEAN JOURNAL OF CANCER |
| 2012 | Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
| 2012 | Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
| PLOS ONE |
| 2010 | Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis | LIVER INTERNATIONAL |
| 2011 | Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. | HEPATOLOGY |
| 2013 | Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
| GUT AND LIVER |
| 2007 | Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma | HEPATOLOGY RESEARCH |
| 2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2009 | Recombinant interferon-Beta-1alpha plus ribavirin for the treatment of chronic HCV infection: a prospective, randomized, comparative pilot study
| GUT AND LIVER |
| 2007 | Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
| CANCER |
| 2009 | Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir | ANTIVIRAL THERAPY |
| 2012 | Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement | DIGESTION |
| 2011 | Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2011 | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | HEPATOLOGY |
| 2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | ONCOLOGY |
